Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 211 - 240 of 287
Previous 30    |  1  2  3  4  5  6  7  8  9  10  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Lopinavir/Ritonavir Viatris (ent. Lopinavir/ritonavir Mylan) - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
LOQTORZI - EMA: EPAR PI
Finnish Swedish

PL

Resepti/itsehoito

Loratadin Holsten 10 mg tabletti SPC 2022-12-09

PL

Resepti/itsehoito

Loratadin ratiopharm 10 mg tabletti SPC 2023-11-15

PL

Resepti

Loratadine Accord 10 mg tabletti SPC 2022-04-14

PL

Resepti/itsehoito

Loraxin 10 mg tabletti SPC 2010-08-23.doc

PL

Resepti

Lorazepam Macure 4 mg-ml injektioneste, liuos SPC 2024-10-10

PL

Resepti

Lorazepam Orion 1 mg tabletti SPC 2024-03-04

European Medicines Agency's website:
Lorviqua - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Losarion 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2020-06-18

PL

Resepti

Losarstad 12.5 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-03-05

PL

Resepti

Losarstad Comp 50 mg-12.5 mg, 100 mg-12.5 mg ja 100 mg-25 mg tabletti, kalvopäällysteinen SPC 2021-11-29

PL

Resepti

Losarstad Comp 50 mg-12.5 mg, 100 mg-12.5 mg, 100 mg-25 mg tabletti kalvopäällysteinen SPC 2021-11-29

PL

Resepti

Losartan Krka 12.5 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2024-01-15

PL

Resepti

Losartan Medical Valley 12.5 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2022-11-23

PL

Resepti

Losartan Orion 12.5 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2021-07-20

PL

Resepti

Losartan STADA 12.5 mg, 25 mg, 50 mg, 100 mg tabletti, kalvopäällysteinen SPC 2023-01-16

PL

Resepti

Losartan-Hydrochlorothiazide Krka 100 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2023-07-06

PL

Resepti

Losartan-Hydrochlorothiazide Krka 100 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-07-06

PL

Resepti

Losartan-Hydrochlorothiazide Krka 50 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2023-07-06

PL

Resepti

Losartan-Hydrochlorothiazide Orion 50 mg-12.5 mg, 100 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-10-18

PL

Resepti

Losartan-Hydrochlorothiazide Sandoz 100 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2022-06-21

PL

Resepti

Losartan-Hydrochlorothiazide STADA 50 mg-12.5 mg, 100 mg-12.5 mg, 100 mg-25 mg tabletti, kalvopäällysteinen SPC 2023-01-23

PL

Resepti

Losatrix 12.5 mg tabletti, kalvopäällysteinen SPC 2024-05-06

PL

Resepti

Losatrix 25mg, 50mg, 100mg tabletti SPC 2024-05-06

PL

Resepti

Losatrix Comp 100 mg-12.5 mg tabletti, kalvopäällysteinen SPC 2022-06-06

PL

Resepti

Losatrix Comp 50 mg-12.5 mg, 100 mg-25 mg tabletti, kalvopäällysteinen SPC 2022-10-03

PL

Itsehoito

Losec 20 mg enterotabletti SPC 2023-03-09

PL

Resepti

Losec MUPS 10 mg, 20 mg enterotabletti SPC 2023-06-26

PL

Resepti

Lotorin 50 mg/g ihovaahto SPC 2024-01-15

Previous 30    |  1  2  3  4  5  6  7  8  9  10  |  Next 30   >